Our Testimonials

READ OUR TESTIMONIALS

We have established strong and lasting relationships with our clients. Here are some things they had to say about us.

"We have been working with Venn Life Sciences for several years on two compounds requiring sophisticated formulation development work. Their deep knowledge and expertise in formulation development enabled us to initiate clinical trials of both programs. Through the collaboration with Venn, we were also able to access to the outstanding features of other services, including CMC, Non-Clinical and Early Clinical consultancy/operational services to achieve the goal. They are talented and committed individuals with great expertise in the scientific and regulatory landscape, and always willing to support us to overcome a number of challenges faced on the projects. I now consider them as a part of our clinical development team”
Akinori Arimura, PhD
Director, Clinical Development, Carna Biosciences, Inc.
More About Carna
Jonathan Back
Director Translational Research of GlycoEra AG in Schlieren, Zwitserland.
More About GlycoEra
“I highly appreciated the flexibility of Vennlife to provide a custom PK analysis with a very short timeline.”
"We have been delighted to work with Venn Life Sciences on a complex clinical trial.”
Professor Keith G. Oldroyd
Director of Research and Development at Golden Jubilee National Hospital
More About Golden Jubilee National Hospital
Bradley Joblin
Study Design & Clinical Development Specialist, Founder
More About Armstrong Clinical
“Want to send a thanks to my friends at Venn Life Sciences. After I reached out to the Linked community asking for help to a European regulatory hurdle, they gave their time and found the solution allowing our study in a rare disease to progress. Very grateful.”
"We have been delighted with the work produced by the Venn Life Sciences team to date. We have been working with them closely since the inception of Poolbeg Pharma and their team has been instrumental in guiding our clinical and pre-clinical programs. We look forward to further collaborations with Venn on future projects.”
Jeremy Skillington
PhD, CEO of Poolbeg Pharma
More About Poolbeg Pharma
arrow-down